Related Experiment Video
Updated: Jun 14, 2026
08:50
Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice
Published on: October 18, 2024
Bariatric surgery: a cutting-edge cure for Type 2 diabetes?
James Coleman1, Simon Phillips
1Department of Medical Education, Maurice Shock Medical Sciences Building, University of Leicester, PO Box 138, Leicester, LE1 9HN, UK.
The New Zealand Medical Journal
|April 3, 2010
Summary
Bariatric surgery shows promise for curing Type 2 diabetes, potentially by increasing insulin-releasing gut hormones. This paper explores the complex and controversial aspects of using bariatric surgery for diabetes management.
Area of Science:
- Metabolic disorders
- Surgical interventions
Background:
- Type 2 diabetes is a growing global health crisis with significant comorbidities and societal costs.
- Existing treatments for Type 2 diabetes are insufficient for many patients.
- Bariatric surgery is emerging as a potential treatment for Type 2 diabetes.
Purpose of the Study:
- To explore the complex issues surrounding bariatric surgery for Type 2 diabetes.
- To highlight the controversial aspects of this treatment modality.
Main Methods:
- Review of current evidence on bariatric surgery and Type 2 diabetes.
- Analysis of proposed mechanisms for surgical remission of diabetes.
- Discussion of associated comorbidities and benefits.
Main Results:
- Evidence suggests bariatric surgery can cure Type 2 diabetes in select individuals.
- Improved comorbidities and reduced financial burden are potential benefits.
- Increased post-surgical release of insulin-promoting gut hormones is a leading hypothesis.
Conclusions:
- Bariatric surgery offers a potential solution for Type 2 diabetes.
- Further research is needed to understand the mechanisms and optimize patient selection.
- The use of bariatric surgery for Type 2 diabetes presents complex and controversial issues.
Related Concept Videos
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...